IFNG and colorectal carcinoma: Moreover, integrating our experimental PCA/correlation results with the GSEA findings places TIGIT in CRC firmly in the context of an IFN-g-driven, immune-inflamed TME, where active antitumor immunity coexists with checkpoint-mediated restraint.